Oral pill trial aims to rival injection for dialysis Patients' anemia

This study is testing whether a new oral medication called QLG1218 (daprodustat) works as well as the standard injected drug (darbepoetin alfa) for treating anemia in people with kidney failure who require dialysis. It will enroll 100 Chinese adults currently receiving dialysis and using standard anemia injections. The main goal is to see if the new pill is not worse than the injection at maintaining healthy red blood cell levels over about 32 weeks.